Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKesson
Johnson and Johnson
Baxter
Medtronic

Last Updated: September 25, 2022

Patent: 6,309,663


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 6,309,663
Title: Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
Abstract:The present invention relates to pharmaceutical compositions, pharmaceutical systems, and methods for enhanced absorption of hydrophilic therapeutic agents. Compositions and systems of the present invention include an absorption enhancing carrier, where the carrier is formed from a combination of at least two surfactants, at least one of which is hydrophilic. A hydrophilic therapeutic agent can be incorporated into the composition, or can be co-administered with the composition as part of a pharmaceutical system. The invention also provides methods of treatment with hydrophilic therapeutic agents using these compositions and systems.
Inventor(s): Patel; Mahesh V. (Salt Lake City, UT), Chen; Feng-Jing (Salt Lake City, UT)
Assignee: Lipocine Inc. (Salt Lake City, UT)
Application Number:09/375,636
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,309,663
Patent Claims:see list of patent claims

Details for Patent 6,309,663

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 08/22/1975 See Plans and Pricing 2039-02-26
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 05/20/1985 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 10/28/1982 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 12/29/2015 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 08/06/1998 See Plans and Pricing 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Express Scripts
Baxter
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.